Immediate Impact

2 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

The senescence-associated secretory phenotype and its physiological and pathological implications
2024 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
2 intermediate papers

Works of Doug Lorenz being referenced

Adjuvant Chemotherapy for Breast Cancer: How Presentation of Recurrence Risk Influences Decision-Making
2003

Author Peers

Author Last Decade Papers Cites
Doug Lorenz 38 59 44 72 67 15 293
Christopher C. Stewart 42 11 90 32 53 19 322
Audrey Morrison 55 43 24 109 54 19 324
Vijay Krishnan 14 31 47 36 26 28 335
Ni Zhou 31 19 15 38 22 29 330
Anand Bhattacharya 103 35 10 24 54 15 319
Andrew J. Lawton 50 96 36 67 20 24 299
Sanjiv Mehta 36 39 43 71 10 21 295
Laura McMillan 61 34 16 60 61 16 294
Levent Bayman 63 28 8 93 28 19 308
Leslea Brickner 46 36 11 46 66 11 318

All Works

Loading papers...

Rankless by CCL
2026